Neuroinflammation Biomarker-Guided Immunomodulation for GBA Carriers
🧪 Overview
Early-stage immunomodulatory therapy guided by inflammatory biomarkers could prevent transition from GBA carrier status to clinical Parkinson's disease.
Debate provenance: derived from debate `sess_SDA-2026-04-10-gba-pd` on question: GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Biomarker-Guided, Carriers, GBA, IL1B, Immunomodulation, Neuroinflammation, modulation, neuroinflammation. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
GBA_mutations["GBA mutations"] -->|associated with| Parkinson_s_disease["Parkinson's_disease"]
GBA["GBA"] -->|encodes| glucocerebrosidase["glucocerebrosidase"]
glucocerebrosidase_1["glucocerebrosidase"] -->|associated with| Alpha_Synuclein_Accumulat["Alpha-Synuclein Accumulation"]
GBA_deficiency["GBA deficiency"] -->|causes| Alpha_Synuclein_Accumulat_2["Alpha-Synuclein Accumulation"]
alpha_synuclein_aggregate["alpha-synuclein aggregates"] -->|causes| glucocerebrosidase_dysfun["glucocerebrosidase dysfunction"]
TFEB["TFEB"] -->|activates| lysosomal_biogenesis["lysosomal_biogenesis"]
autophagy_pathway["autophagy_pathway"] -->|regulates| lysosomal_degradation["lysosomal degradation"]
TFEB_activation["TFEB activation"] -->|enhances| alpha_synuclein_clearance["alpha-synuclein clearance"]
TFEB_activation_3["TFEB activation"] -->|associated with| GBA_enzyme_function["GBA enzyme function"]
mTORC1_inhibitors["mTORC1 inhibitors"] -->|activates| TFEB_4["TFEB"]
Ampk_Activators["Ampk Activators"] -->|activates| TFEB_5["TFEB"]
neuroinflammation["neuroinflammation"] -->|associated with| GBA_carrier_to_PD_progres["GBA carrier to PD progression"]
style GBA_mutations fill:#ce93d8,stroke:#333,color:#000
style Parkinson_s_disease fill:#ef5350,stroke:#333,color:#000
style GBA fill:#ce93d8,stroke:#333,color:#000
style glucocerebrosidase fill:#4fc3f7,stroke:#333,color:#000
style glucocerebrosidase_1 fill:#4fc3f7,stroke:#333,color:#000
style Alpha_Synuclein_Accumulat fill:#4fc3f7,stroke:#333,color:#000
style GBA_deficiency fill:#4fc3f7,stroke:#333,color:#000
style Alpha_Synuclein_Accumulat_2 fill:#4fc3f7,stroke:#333,color:#000
style alpha_synuclein_aggregate fill:#4fc3f7,stroke:#333,color:#000
style glucocerebrosidase_dysfun fill:#4fc3f7,stroke:#333,color:#000
style TFEB fill:#ce93d8,stroke:#333,color:#000
style lysosomal_biogenesis fill:#4fc3f7,stroke:#333,color:#000
style autophagy_pathway fill:#81c784,stroke:#333,color:#000
style lysosomal_degradation fill:#4fc3f7,stroke:#333,color:#000
style TFEB_activation fill:#4fc3f7,stroke:#333,color:#000
style alpha_synuclein_clearance fill:#4fc3f7,stroke:#333,color:#000
style TFEB_activation_3 fill:#4fc3f7,stroke:#333,color:#000
style GBA_enzyme_function fill:#4fc3f7,stroke:#333,color:#000
style mTORC1_inhibitors fill:#4fc3f7,stroke:#333,color:#000
style TFEB_4 fill:#ce93d8,stroke:#333,color:#000
style Ampk_Activators fill:#4fc3f7,stroke:#333,color:#000
style TFEB_5 fill:#4fc3f7,stroke:#333,color:#000
style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
style GBA_carrier_to_PD_progres fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — IL1B
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for IL1B.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |